Shunle Li

440 total citations
18 papers, 325 citations indexed

About

Shunle Li is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Shunle Li has authored 18 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Shunle Li's work include Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (5 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Shunle Li is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (5 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Shunle Li collaborates with scholars based in China, United States and Japan. Shunle Li's co-authors include Tao Wu, Tao Shan, Shuo Chen, Tao Wu, Xinwu Zhang, Xiaoli Sun, Di Zhang, Xi Chen, Xi Chen and Yi Yang and has published in prestigious journals such as World Journal of Gastroenterology, Ecotoxicology and Environmental Safety and Biomedicine & Pharmacotherapy.

In The Last Decade

Shunle Li

18 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shunle Li China 11 172 121 100 86 54 18 325
Pengfei Sun China 13 178 1.0× 108 0.9× 73 0.7× 70 0.8× 27 0.5× 24 328
Jinfeng Gan China 10 203 1.2× 91 0.8× 98 1.0× 51 0.6× 27 0.5× 21 324
Qishun Geng China 11 232 1.3× 108 0.9× 86 0.9× 58 0.7× 21 0.4× 28 382
Zhaojie Lyu China 9 195 1.1× 88 0.7× 61 0.6× 71 0.8× 38 0.7× 21 362
Xiaojie Gan China 12 143 0.8× 87 0.7× 64 0.6× 99 1.2× 50 0.9× 23 334
Yongsu Ma China 12 149 0.9× 108 0.9× 196 2.0× 48 0.6× 98 1.8× 31 374
Chenfeng Wang China 13 259 1.5× 144 1.2× 70 0.7× 41 0.5× 30 0.6× 25 387
Cuiping Wang China 12 176 1.0× 79 0.7× 54 0.5× 68 0.8× 28 0.5× 26 312
Jianzhong Lin China 8 158 0.9× 84 0.7× 60 0.6× 70 0.8× 31 0.6× 13 294
Jingtai Zhi China 13 231 1.3× 77 0.6× 102 1.0× 31 0.4× 65 1.2× 29 443

Countries citing papers authored by Shunle Li

Since Specialization
Citations

This map shows the geographic impact of Shunle Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shunle Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shunle Li more than expected).

Fields of papers citing papers by Shunle Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shunle Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shunle Li. The network helps show where Shunle Li may publish in the future.

Co-authorship network of co-authors of Shunle Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shunle Li. A scholar is included among the top collaborators of Shunle Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shunle Li. Shunle Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Li, Rong, Shunle Li, Lin Shen, et al.. (2025). M6A-modified BFSP1 induces aerobic glycolysis to promote liver cancer growth and metastasis through upregulating tropomodulin 4. Molecular Biomedicine. 6(1). 17–17. 2 indexed citations
2.
Li, Rong, Shunle Li, Hua Li, et al.. (2025). WTAP Accelerates Exhaustion of CD8 + T Cells and Progression of Hepatocellular Carcinoma by Promoting m6A Modification and Translation of PD1 mRNA. Mediators of Inflammation. 2025(1). 6217272–6217272. 1 indexed citations
3.
Rong, Li, Shunle Li, Lin Shen, et al.. (2024). LINC00618 facilitates growth and metastasis of hepatocellular carcinoma via elevating cholesterol synthesis by promoting NSUN2-mediated SREBP2 m5C modification. Ecotoxicology and Environmental Safety. 285. 117064–117064. 10 indexed citations
4.
Li, Rong, Shunle Li, Lin Shen, et al.. (2023). SNHG1 , interacting with SND1 , contributes to sorafenib resistance of liver cancer cells by increasing m6A ‐mediated SLC7A11 expression and promoting aerobic glycolysis. Environmental Toxicology. 39(3). 1269–1282. 6 indexed citations
5.
Li, Rong, Longbao Yang, Shunle Li, et al.. (2023). C/EBPα alleviates hepatic ischemia‐reperfusion injury by inhibiting endoplasmic reticulum stress via HDAC1‐mediated deacetylation of ATF4. Journal of Biochemical and Molecular Toxicology. 38(1). e23630–e23630. 4 indexed citations
6.
Shen, Lin, Jing Zhang, Meng Xu, et al.. (2022). DDX3 acts as a tumor suppressor in colorectal cancer as loss of DDX3 in advanced cancer promotes tumor progression by activating the MAPK pathway. International Journal of Biological Sciences. 18(10). 3918–3933. 10 indexed citations
7.
Li, Rong, Runze Shang, Shunle Li, et al.. (2022). LOXL3‐promoted hepatocellular carcinoma progression via promotion of Snail1/USP4‐mediated epithelial‐mesenchymal transition. Environmental Toxicology. 37(10). 2540–2551. 14 indexed citations
8.
Li, Hua, et al.. (2022). Circ_SNX27 regulates hepatocellular carcinoma development via miR‐637/FGFR1 axis. Environmental Toxicology. 37(12). 2832–2843. 7 indexed citations
9.
Shan, Tao, Shuo Chen, Xi Chen, et al.. (2020). M2‑TAM subsets altered by lactic acid promote T‑cell apoptosis through the PD‑L1/PD‑1 pathway. Oncology Reports. 44(5). 1885–1894. 77 indexed citations
10.
Li, Shunle, et al.. (2020). RP11‑619L19.2 promotes colon cancer development by regulating the miR‑1271‑5p/CD164 axis. Oncology Reports. 44(6). 2419–2428. 7 indexed citations
11.
Li, Shunle, Tao Wu, Di Zhang, Xiaoli Sun, & Xinwu Zhang. (2019). The long non‐coding RNA HCG18 promotes the growth and invasion of colorectal cancer cells through sponging miR‐1271 and upregulating MTDH/Wnt/β‐catenin. Clinical and Experimental Pharmacology and Physiology. 47(4). 703–712. 48 indexed citations
12.
Shan, Tao, Shuo Chen, Tao Wu, et al.. (2019). PD-L1 expression in colon cancer and its relationship with clinical prognosis.. PubMed. 12(5). 1764–1769. 51 indexed citations
13.
Li, Hua, Xin Xu, Yang Liu, et al.. (2018). MMP7 Induces T-DM1 Resistance and Leads to the Poor Prognosis of Gastric Adenocarcinoma via a DKK1-Dependent Manner. Anti-Cancer Agents in Medicinal Chemistry. 18(14). 2010–2016. 12 indexed citations
14.
Li, Shunle, Xi Chen, Tao Wu, et al.. (2018). Knockdown of TMPRSS3 inhibits gastric cancer cell proliferation, invasion and EMT via regulation of the ERK1/2 and PI3K/Akt pathways. Biomedicine & Pharmacotherapy. 107. 841–848. 17 indexed citations
15.
Li, Hua, et al.. (2018). Ginkgolic acid suppresses the invasion of HepG2 cells via downregulation of HGF/c‑Met signaling. Oncology Reports. 41(1). 369–376. 18 indexed citations
16.
Li, Shunle, et al.. (2012). Role of heparin on serum VEGF levels and local VEGF contents in reducing the severity of experimental severe acute pancreatitis in rats. Scandinavian Journal of Gastroenterology. 47(2). 237–244. 11 indexed citations
17.
Li, Shunle, et al.. (2012). Low-dose heparin in the prevention of post endoscopic retrograde cholangiopancreatography pancreatitis. European Journal of Gastroenterology & Hepatology. 24(5). 477–481. 15 indexed citations
18.
Chen, Xi, Shunle Li, Tao Wu, & Jidong Liu. (2008). Proteasome inhibitor ameliorates severe acute pancreatitis and associated lung injury of rats. World Journal of Gastroenterology. 14(20). 3249–3249. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026